Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | $9.27B | $10.2B | $22.3B | $26.6B | $26.9B | $28.9B | $30.3B | $31.0B | $31.8B |
| Revenue growth | — | — | 10.3% | 118.5% | 18.9% | 1.5% | 7.3% | 4.6% | 2.3% | 2.6% |
| Gross profit | $1.28B | $1.43B | $1.52B | $3.22B | $3.89B | $3.94B | $4.18B | $4.13B | $4.20B | $4.22B |
| Gross margin | — | 15.4% | 14.9% | 14.4% | 14.6% | 14.6% | 14.5% | 13.6% | 13.6% | 13.3% |
| Operating income | $224M | $226M | $224M | -$196M | -$193M | $294M | $423M | $120M | $8.00M | -$31.0M |
| Operating margin | — | 2.4% | 2.2% | -0.9% | -0.7% | 1.1% | 1.5% | 0.4% | 0.0% | -0.1% |
| Net income | $126M | $130M | $163M | -$285M | -$274M | $149M | $248M | $24.0M | -$112M | -$118M |
| Net margin | — | 1.4% | 1.6% | -1.3% | -1.0% | 0.6% | 0.9% | 0.1% | -0.4% | -0.4% |
| EPS (diluted) | — | $2.56 | $3.20 | -$5.56 | -$5.10 | $2.48 | $4.07 | $0.40 | -$1.89 | -$1.95 |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $297M | $273M | $109M | $285M | $457M | $614M | $331M | $624M | $253M | $470M |
| Capital expenditures | $41.4M | $56.1M | $44.6M | $228M | $173M | $310M | $251M | $323M | $345M | $231M |
| Free cash flow | $255M | $217M | $64.4M | $57.0M | $284M | $304M | $80.0M | $301M | -$92.0M | $239M |
| Share buybacks | $0.00 | $0.00 | $24.2M | $0.00 | $0.00 | $0.00 | $0.00 | $62.0M | $0.00 | $0.00 |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $18.6M | $15.4M | $23.3M | $44.5M | $47.0M | $41.0M | $44.0M | $37.0M | $40.0M | $44.0M |
| Total assets | $2.85B | $2.89B | $2.96B | $7.17B | $7.59B | $7.53B | $7.63B | $7.39B | $7.53B | $7.59B |
| Total liabilities | $1.33B | $1.20B | $1.12B | $5.67B | $6.45B | $6.01B | $5.84B | $5.65B | $5.89B | $6.04B |
| Long-term debt | $162M | $150M | $138M | $3.00B | $2.58B | $2.17B | $2.11B | $1.96B | $2.08B | $1.86B |
| Shareholders' equity | $1.52B | $1.68B | $1.85B | $1.51B | $1.15B | $1.51B | $1.79B | $1.74B | $1.64B | $1.55B |
| Retained earnings | $1.11B | $1.24B | $1.40B | $1.11B | $838M | $978M | $1.23B | $1.25B | $1.14B | $1.02B |
| Shares (wtd avg diluted) | 50.4M | 50.8M | 50.8M | 51.2M | 53.8M | 60.0M | 61.0M | 60.7M | 59.3M | 60.2M |
Every figure is extracted from UNITED NATURAL FOODS INC’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.